{"id":11259,"date":"2025-11-06T07:00:00","date_gmt":"2025-11-06T07:00:00","guid":{"rendered":"https:\/\/acarix.com\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\/"},"modified":"2025-11-06T07:00:00","modified_gmt":"2025-11-06T07:00:00","slug":"acarix-ab-publ-publicerar-tredje-kvartalet-2025","status":"publish","type":"post","link":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\/","title":{"rendered":"Acarix AB (publ) publicerar tredje kvartalet 2025"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p class=\"mfn-wp-retain\"><strong>Malm&ouml;, &ndash; Acarix, ledande inom akustisk- och algoritmbaserad hj&auml;rtdiagnostik, redovisade idag sina finansiella resultat f&ouml;r det tredje kvartalet 2025. Rapporten belyser internationell expansion, fortsatta framsteg i USA g&auml;llande f&ouml;rs&auml;kringsbolag och ers&auml;ttningar samt positiva resultat.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p class=\"mfn-wp-retain\">&#8220;Det tredje kvartalet blev en avg&ouml;rande period f&ouml;r Acarix, k&auml;nnetecknat av betydande tillv&auml;xt och en noggrann och disciplinerad strategi p&aring; v&aring;ra marknader,&#8221; s&auml;ger Aamir Mahmood, President &amp; CEO f&ouml;r Acarix. &#8220;Int&auml;kterna &ouml;kade med 137 % j&auml;mf&ouml;rt med samma period f&ouml;reg&aring;ende &aring;r, drivet av v&aring;r f&ouml;rsta kommersiella f&ouml;rs&auml;ljning i MENA-regionen och ett fortsatt momentum i USA. Samtidigt minskade driftskostnaderna med 43% och nettof&ouml;rlusten f&ouml;rb&auml;ttrades med 49%, vilket understryker v&aring;r f&ouml;rm&aring;ga att v&auml;xa effektivt samtidigt som vi uppr&auml;tth&aring;ller finansiell kontroll. <br \/>I USA har tre av de fem st&ouml;rsta f&ouml;rs&auml;kringsbolagen nu tagit bort &#8216;experimentell&#8217;-etiketten f&ouml;r CADScor&reg;, och vi har dessutom s&auml;krat ett andra f&ouml;rs&auml;kringsbolag som erbjuder en fast ers&auml;ttning p&aring; 300 USD per CADScor-test &ndash; vilket ytterligare bekr&auml;ftades i oktober n&auml;r HealthChoice, Oklahomas sj&auml;lvfinansierade f&ouml;rs&auml;kringsplan, inf&ouml;rde kostnadsers&auml;ttning. <br \/>Internationellt visar v&aring;r distribut&ouml;rsmodell att den &auml;r b&aring;de skalbar och kapitaleffektiv, vilket l&auml;gger grunden f&ouml;r fortsatt expansion under 2026.<br \/>Med kommersiell framg&aring;ng, &ouml;kad t&auml;ckning fr&aring;n f&ouml;rs&auml;kringsbolagen och betydande innovationer som v&aring;r Heart Failure Seismo AI-algoritm, som har godk&auml;nts f&ouml;r presentation p&aring; American Heart Association Congress i november 2025, &auml;r Acarix v&auml;l positionerat f&ouml;r att forts&auml;tta v&auml;xa och skapa l&aring;ngsiktigt v&auml;rde f&ouml;r aktie&auml;garna. Samtidigt forts&auml;tter vi att omdefiniera hur hj&auml;rt-k&auml;rldiagnostik kan f&ouml;rb&auml;ttras f&ouml;r relevanta patientgrupper.<\/p>\n<p class=\"mfn-wp-retain\"><strong>Tredje kvartalet 2025 j&auml;mf&ouml;rt med samma period 2024<\/strong><\/p>\n<ul>\n<li>Totala int&auml;kter uppgick till 2 350 kSEK (993) vilket motsvarar en tillv&auml;xt p&aring; 137 procent<\/li>\n<li>I USA uppgick int&auml;kterna till 766 kSEK (652), en &ouml;kning med 17 procent<\/li>\n<li>Antalet levererade CADScor-system uppgick till totalt 39 enheter (20) vilket motsvarar en &ouml;kning med 95 procent. Av dessa levererades 22 enheter till den amerikanska marknaden p&aring; konsignation, medan 17 enheter s&aring;ldes inom MENA-regionen<\/li>\n<li>S&aring;lda patcher uppgick till totalt 211 boxar (117) vilket motsvarar en &ouml;kning p&aring; 80 procent. (Varje box inneh&aring;ller 20 patcher)<\/li>\n<li>P&aring; den amerikanska marknaden uppgick f&ouml;rs&auml;ljningen av patcher till 78 boxar (69) vilket motsvarar en &ouml;kning med 13 procent<\/li>\n<li>Bruttomarginalen f&ouml;r perioden uppgick till 85 procent (90)<\/li>\n<li>De totala r&ouml;relsekostnaderna uppgick till 11 168 kSEK (19 447), motsvarande en minskning med 43 procent<\/li>\n<li>Nettof&ouml;rlusten uppgick till -9 445 kSEK (18 574) vilket motsvarar en f&ouml;rb&auml;ttring p&aring; 49 procent j&auml;mf&ouml;rt med f&ouml;reg&aring;ende period<\/li>\n<li>Kassafl&ouml;de fr&aring;n den l&ouml;pande verksamheten uppgick till -7 161 kSEK (-12 990)<\/li>\n<li>Resultat per aktie (EPS) var -0 01 SEK (-0 02 SEK)<\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\"><strong>De f&ouml;rsta nio m&aring;naderna av 2025 j&auml;mf&ouml;rt med samma period 2024<\/strong><\/p>\n<ul>\n<li>Totala int&auml;kter uppgick till 5 220 kSEK (4 503) vilket &auml;r en &ouml;kning med 16 procent<\/li>\n<li>P&aring; den amerikanska marknaden uppgick int&auml;kterna till 2 596 kSEK (2 656), en minskning med 2 procent<\/li>\n<li>Totalt levererades 78 CADScor-system (48), en &ouml;kning med 62 procent<\/li>\n<li>I USA levereras 60 CADScor-system (47), en &ouml;kning med 28 procent<\/li>\n<li>F&ouml;rs&auml;ljningen av patcher uppgick till 508 boxar (420), en &ouml;kning med 21 procent<\/li>\n<li>I USA s&aring;ldes 254 boxar patcher (184), en &ouml;kning med 38 procent<\/li>\n<li>Bruttomarginalen var 86 % (91)<\/li>\n<li>R&ouml;relsekostnaderna uppgick till 40 521 kSEK (54 156 kSEK), en minskning med 25 procent<\/li>\n<li>Nettof&ouml;rlusten uppgick till -36 417 kSEK (-50 166), en f&ouml;rb&auml;ttring med 27 procent<\/li>\n<li>Kassafl&ouml;det fr&aring;n den l&ouml;pande verksamheten uppgick -31 493 kSEK (-46 685)<\/li>\n<li>Resultatet per aktie var -0 03 SEK (-0 06 SEK)<\/li>\n<li>Det genomsnittliga antalet aktier uppgick till 1 123 320 142 (866 503 102)<\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\"><strong>Webbcast-presentationen av del&aring;rsrapporten f&ouml;r tredje kvartalet finns tillg&auml;nglig p&aring;: <\/strong><a href=\"https:\/\/www.acarix.com\/investor-presentations\/\" rel=\"noopener\" target=\"_blank\">https:\/\/www.acarix.com\/investor-presentations\/<\/a><\/p>\n<p class=\"mfn-wp-retain\"><strong>L&auml;nk till Acarix finansiella rapporter: <\/strong><strong><br \/><\/strong><a href=\"https:\/\/www.acarix.com\/for-investors\/financial-reports-and-calendar\" rel=\"noopener\" target=\"_blank\">https:\/\/www.acarix.com\/for-investors\/financial-reports-and-calendar<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-ddf9d1ef3849\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">Om Acarix<\/strong><\/p>\n<table style=\"border-collapse: collapse;margin-bottom: 1em;margin-top: 1em\">\n<tbody>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" valign=\"middle\">Acarix &auml;r ett svenskt medicintekniskt f&ouml;retag som utvecklar l&ouml;sningar f&ouml;r att snabbt utesluta kransk&auml;rlssjukdom (CAD) vid patientn&auml;ra v&aring;rd. Det CE-godk&auml;nda och FDA DeNovo-godk&auml;nda Acarix CADScor-systemet &auml;r avsett f&ouml;r patienter som upplever br&ouml;stsm&auml;rta med misst&auml;nkt kransk&auml;rlssjukdom och &auml;r utformat f&ouml;r att bidra till att minska miljontals on&ouml;diga, invasiva och kostsamma diagnostiska procedurer. CADScor-systemet har anv&auml;nts p&aring; mer &auml;n 40 000 patienter. Acarix rekommenderar CADScor System som ett f&ouml;rsta linjens diagnostiskt hj&auml;lpmedel som anv&auml;nder mycket k&auml;nslig akustik och avancerad ber&auml;kningsbearbetning f&ouml;r att analysera kransk&auml;rlsblodfl&ouml;det f&ouml;r att utesluta betydande kransk&auml;rlssjukdom (CAD), med minst 96 % s&auml;kerhet vid v&aring;rdtillf&auml;llet. Acarix &auml;r noterat p&aring; Nasdaq First North Premier Growth Market i Stockholm (ticker: ACARIX) och kan &auml;ven handlas i USA p&aring; OTCQB-marknaden (ticker: ACIXF). Bolagets Certified Adviser &auml;r Tapper Partners AB. F&ouml;r mer information, bes&ouml;k <a href=\"http:\/\/www.acarix.com\" rel=\"noopener\" target=\"_blank\">www.acarix.com<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"mfn-footer mfn-bb68ac3e1d46\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">F&ouml;r ytterligare information, kontakta<\/strong><br \/>Macie May, telefon +1 405 517 5161, email <a href=\"mailto:awilson@saxum.com\" rel=\"noopener\" target=\"_blank\">mmay@saxum.com<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><br \/><a class=\"mfn-primary\" href=\"https:\/\/storage.mfn.se\/99b14d9f-0f18-4434-abcc-11a1c64852d4\/acarix-q3-swedish-report-final-2511050933.pdf\" rel=\"noopener\" target=\"_blank\">Acarix Q3 Swedish Report Final 2511050933<\/a><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment mfn-primary\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/99b14d9f-0f18-4434-abcc-11a1c64852d4\/acarix-q3-swedish-report-final-2511050933.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/99b14d9f-0f18-4434-abcc-11a1c64852d4\/acarix-q3-swedish-report-final-2511050933.pdf?type=jpg\"><\/span>Acarix Q3 Swedish Report Final 2511050933<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Malm&ouml;, &ndash; Acarix, ledande inom akustisk- och algoritmbaserad hj&auml;rtdiagnostik, redovisade idag sina finansiella resultat f&ouml;r det tredje kvartalet 2025. Rapporten<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[157,140,154,139,160,148,155,142],"tags":[],"class_list":["post-11259","post","type-post","status-publish","format-standard","hentry","category-mfn-report-interim","category-mfn-type-ir","category-mfn-regulatory-listing","category-mfn","category-mfn-report-interim-q3","category-mfn-regulatory","category-mfn-report","category-mfn-lang-sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Acarix AB (publ) publicerar tredje kvartalet 2025 - Acarix<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acarix AB (publ) publicerar tredje kvartalet 2025 - Acarix\" \/>\n<meta property=\"og:description\" content=\"Malm&ouml;, &ndash; Acarix, ledande inom akustisk- och algoritmbaserad hj&auml;rtdiagnostik, redovisade idag sina finansiella resultat f&ouml;r det tr\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Acarix\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-06T07:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"673\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Acarix AB (publ) publicerar tredje kvartalet 2025\",\"datePublished\":\"2025-11-06T07:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\\\/\"},\"wordCount\":984,\"articleSection\":[\"Interim\",\"IR\",\"Listing Regulation\",\"News\",\"Q3\",\"Regulatory\",\"Report\",\"Swedish\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\\\/\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\\\/\",\"name\":\"Acarix AB (publ) publicerar tredje kvartalet 2025 - Acarix\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\"},\"datePublished\":\"2025-11-06T07:00:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acarix AB (publ) publicerar tredje kvartalet 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\",\"name\":\"Acarix\",\"description\":\"CADScor\u00aeSystem\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acarix AB (publ) publicerar tredje kvartalet 2025 - Acarix","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Acarix AB (publ) publicerar tredje kvartalet 2025 - Acarix","og_description":"Malm&ouml;, &ndash; Acarix, ledande inom akustisk- och algoritmbaserad hj&auml;rtdiagnostik, redovisade idag sina finansiella resultat f&ouml;r det tr","og_url":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\/","og_site_name":"Acarix","article_published_time":"2025-11-06T07:00:00+00:00","og_image":[{"width":1200,"height":673,"url":"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\/#article","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\/"},"author":{"name":"","@id":""},"headline":"Acarix AB (publ) publicerar tredje kvartalet 2025","datePublished":"2025-11-06T07:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\/"},"wordCount":984,"articleSection":["Interim","IR","Listing Regulation","News","Q3","Regulatory","Report","Swedish"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\/","url":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\/","name":"Acarix AB (publ) publicerar tredje kvartalet 2025 - Acarix","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#website"},"datePublished":"2025-11-06T07:00:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d.ptpl.dev\/acarix\/"},{"@type":"ListItem","position":2,"name":"Acarix AB (publ) publicerar tredje kvartalet 2025"}]},{"@type":"WebSite","@id":"https:\/\/d.ptpl.dev\/acarix\/#website","url":"https:\/\/d.ptpl.dev\/acarix\/","name":"Acarix","description":"CADScor\u00aeSystem","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d.ptpl.dev\/acarix\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/11259","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/comments?post=11259"}],"version-history":[{"count":0,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/11259\/revisions"}],"wp:attachment":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/media?parent=11259"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/categories?post=11259"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/tags?post=11259"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}